Designing a Virtual Reality Intervention to Improve Physical and Psychological Health in Intensive Care Units
Launched by DUKE UNIVERSITY · Jan 27, 2025
Trial Information
Current as of November 15, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether Virtual Reality (VR) can help patients in the cardiothoracic Intensive Care Unit (ICU) move more easily and improve their mood. Participants will be asked to fill out a survey about feelings like anxiety, depression, and loneliness. They will learn how to use a VR device and play a game designed to encourage movement, such as using their arms and hands to dance or hit objects in a virtual world. The goal is for them to play the game at least once a day, but they are welcome to play more if they wish.
To be eligible for this trial, participants need to be adults who speak English and have been in the ICU for at least three days with limited ability to move. However, those who are pregnant, have severe visual impairments, a history of seizures, or are currently intubated or sedated cannot participate. This study is currently recruiting participants, and it aims to provide a fun and engaging way for patients to improve their physical and emotional health while in the ICU.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult
- • English speaking
- • 3+ days ICU admission with limited mobility
- Exclusion Criteria:
- • Pregnancy
- • Blind/severe visual impairment
- • History of seizures
- • Intubation/sedation
- • Special enteric contact isolation
About Duke University
Duke University, a leading academic and research institution located in Durham, North Carolina, is renowned for its commitment to advancing healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, Duke conducts a wide array of clinical trials aimed at developing cutting-edge therapies and improving patient outcomes across various medical fields. The university's Clinical Research Institute provides comprehensive support for trial design, implementation, and regulatory compliance, ensuring that all research adheres to the highest ethical and scientific standards. Duke’s dedication to translating research findings into effective clinical practices underscores its role as a pivotal contributor to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Durham, North Carolina, United States
Patients applied
Trial Officials
Anna E Mall, MSN
Principal Investigator
Duke University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported